FAM187B2P: A Drug Target / Disease Biomarker (G100421621)

Target Name: FAM187B2P

NCBI ID: G100421621

FAM187B2P

Other Name(s): family with sequence similarity 187 member B2, pseudogene | Family with sequence similarity 187, member B pseudogene | Family with sequence similarity 187, member B2 pseudogene

FAM187B2P: A Drug Target / Disease Biomarker

FAM187B2P is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 18 and encodes a protein known as FAM187B2.

The FAM187B2 protein is a key regulator of the cell cycle and has been shown to play a role in the development and progression of various diseases. Studies have shown that alterations in the expression of FAM187B2 can contribute to the development of cancer, and that inhibiting the activity of the protein may be a promising strategy for cancer treatment.

One of the key features of FAM187B2 is its ability to interact with a variety of different proteins, including those involved in cell division and apoptosis. This interactivity has led some researchers to consider FAM187B2 as a potential drug target for the treatment of cancer.

In addition to its role in cell division, FAM187B2 has also been shown to be involved in the regulation of cell survival and the production of signaling molecules that promote cell growth. This involvement in cell survival and growth regulation makes FAM187B2 an attractive target for cancer treatment.

Another promising aspect of FAM187B2 is its ability to interact with the protein p53, which is a well-known regulator of DNA damage and repair. Studies have shown that FAM187B2 can interact with p53 and that this interaction may play a role in the regulation of cell growth and apoptosis.

In addition to its potential as a drug target, FAM187B2 has also been identified as a potential biomarker for the diagnosis and prognosis of various diseases. Studies have shown that FAM187B2 is expressed in a variety of tissues and that its expression levels can be affected by a variety of factors, including cancer status, radiation therapy, and certain medications.

Overall, the potential drug target or biomarker status of FAM187B2 makes it an intriguing target for further research and may have important implications for the treatment of various diseases. Further studies are needed to fully understand the role of FAM187B2 in cell division and apoptosis, and to determine its potential as a drug target or biomarker.

Protein Name: Family With Sequence Similarity 187 Member B2, Pseudogene

The "FAM187B2P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM187B2P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets